[Mesoridazine (TPS 23 Sandoz) in acute psychotic states].
D000208:Acute Disease; D000374:Aggression / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003861:Depersonalization / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D008653:Mesoridazine / Q000008:administration & dosage / Q000627:therapeutic use*; D009155:Mutism / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D008653:Mesoridazine
Mesoridazin (TPS 23 Sandoz) bei akuten psychotischen Zuständen.